Evaluation of Dose-Painting in the Dominant Intraprostatic Lesions by Radiobiological Parameters using ۶۸Ga- PSMA PET/CT

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 41

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JBPE-12-4_006

تاریخ نمایه سازی: 30 دی 1402

چکیده مقاله:

Background: Patients diagnosed with dominant intraprostatic lesions (DIL) may need radiation doses over than ۸۰ Gy. Dose-painting by contours (DPC) is a useful technique which helps the patients. Dose-painting approach need to be evaluated. Objective: To evaluate the DCP technique in the case of boosting the DILs by radiobiological parameters, tumor control probability (TCP), and normal tissue complication probability (NTCP) via PET/CT images traced by ۶۸Ga-PSMA.Material and Methods: In this analytical study, ۶۸Ga-PSMA PET/CT images were obtained from patients with DILs that were delineated using the Fuzzy c-mean (FCM) algorithm and thresholding methods. The protocol of therapy included two phases; at the first phase (ph۱), a total dose of ۷۲ Gy in ۳۶ fractions were delivered to the planning target volume (PTV۱); the seconds phase consisted of the application of variable doses to the PTV۲. Moreover, two concepts were also considered to calculate the TCP using the Zaider-Minerbo model. Results: The lowest volume in DILs belonged to the DIL۱ extracted by the FCM method. According to dose-volume parameters of the rectum and bladder, by the increase in the PTV dose higher than ۹۲ Gy, the amounts of rectum and bladder doses are increased. There was no difference between the TCPs of DILs at doses higher than ۸۶ Gy and ۱۰۰ Gy for ordinary and high clone density, respectively.  Conclusion: Consequently, our dose-painting approach for DILs, extracted by the FCM method via PET/CT images, can reduce the total dose for prostate radiation with ۱۰۰% tumor control and less normal tissue complications.

نویسندگان

- -

PhD, Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

- -

PhD, Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran

- -

PhD, Echocardiography Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

- -

PhD, Department of Nuclear Medicine, Shariati Hospital Tehran University of Medical Sciences, Tehran, Iran

- -

PhD, Department of Medical Physics, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran

- -

PhD, Department of Radiology Technology, Faculty of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

- -

PhD, Department of Medical Physics, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Cooper CS, Eeles R, Wedge DC, Van Loo P, Gundem ...
  • Wang T, Press RH, Giles M, Jani AB, Rossi P, ...
  • Uzan J, Nahum AE, Syndikus I. Prostate dose-painting radiotherapy and ...
  • Bentzen SM. Theragnostic imaging for radiation oncology: dose-painting by numbers. ...
  • Cattaneo GM, Bettinardi V, Mapelli P, Picchio M. PET guidance ...
  • Erdi YE, Mawlawi O, Larson SM, Imbriaco M, Yeung H, ...
  • Hatt M, Le Rest CC, Turzo A, Roux C, Visvikis ...
  • Zamboglou C, Klein CM, Thomann B, Fassbender TF, Rischke HC, ...
  • Akhter W, Khan M, Karim O, Motiwala H, Laniado M. ...
  • Chang JH, Gehrke C, Prabhakar R, Gill S, Wada M, ...
  • Cellini N, Morganti AG, Mattiucci GC, Valentini V, Leone M, ...
  • Komek H, Can C, Yilmaz U, Altindag S. Prognostic value ...
  • Bouchelouche K, Oehr P. Recent developments in urologic oncology: positron ...
  • Wang H, Vees H, Miralbell R, Wissmeyer M, Steiner C, ...
  • Pathmanathan AU, Alexander EJ, Huddart RA, Tree AC. The delineation ...
  • Azzeroni R, Maggio A, Fiorino C, Mangili P, Cozzarini C, ...
  • Ruggieri R, Naccarato S, Nahum AE. Severe hypofractionation: non-homogeneous tumour ...
  • Buettner F, Gulliford SL, Webb S, Sydes MR, Dearnaley DP, ...
  • Klayton T, Price R, Buyyounouski MK, Sobczak M, Greenberg R, ...
  • Bauman G, Haider M, Van der Heide UA, Ménard C. ...
  • Niyazi M, Bartenstein P, Belka C, Ganswindt U. Choline PET ...
  • نمایش کامل مراجع